Spatial Domain
Spatial Domain (Tier 1)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__86_A6,9 | Lung | Primary cancer | 1,491 | Tumor/Malignant | 43.7% | 0.93 | 0.21 |
| NSCLC_38242124__IMC__86_A7,1 | Lung | Primary cancer | 2,317 | Tumor/Malignant | 58.9% | 0.97 | 0.08 |
| NSCLC_38242124__IMC__86_A7,10 | Lung | Primary cancer | 2,375 | Tumor/Malignant | 30.7% | 0.96 | 0.19 |
| NSCLC_38242124__IMC__86_A7,11 | Lung | Primary cancer | 2,116 | Stromal | 45.1% | 0.87 | 0.35 |
| NSCLC_38242124__IMC__86_A7,12 | Lung | Primary cancer | 540 | Other | 64.1% | 0.98 | 0.07 |
| NSCLC_38242124__IMC__86_A7,13 | Lung | Primary cancer | 4,267 | Tumor/Malignant | 26.8% | 0.93 | 0.23 |
| NSCLC_38242124__IMC__86_A7,2 | Lung | Primary cancer | 2,945 | Tumor/Malignant | 48.8% | 0.88 | 0.36 |
| NSCLC_38242124__IMC__86_A7,4 | Lung | Primary cancer | 4,008 | Tumor/Malignant | 28.8% | 0.54 | 0.85 |
| NSCLC_38242124__IMC__86_A7,5 | Lung | Primary cancer | 3,313 | Tumor/Malignant | 80.1% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__86_A7,7 | Lung | Primary cancer | 1,967 | Tumor/Malignant | 52.6% | 0.91 | 0.28 |
| NSCLC_38242124__IMC__86_A7,8 | Lung | Primary cancer | 2,968 | Stromal | 49.4% | 0.96 | 0.14 |
| NSCLC_38242124__IMC__86_A7,9 | Lung | Primary cancer | 2,881 | Other | 31.9% | 0.40 | 0.98 |
| NSCLC_38242124__IMC__86_A8,1 | Lung | Primary cancer | 2,834 | Tumor/Malignant | 31.0% | 0.77 | 0.62 |
| NSCLC_38242124__IMC__86_A8,10 | Lung | Primary cancer | 3,285 | Immune | 35.6% | 0.50 | 0.88 |
| NSCLC_38242124__IMC__86_A8,11 | Lung | Primary cancer | 2,883 | Stromal | 31.2% | 0.56 | 0.80 |
| NSCLC_38242124__IMC__86_A8,12 | Lung | Primary cancer | 3,110 | Tumor/Malignant | 61.4% | 0.98 | 0.07 |
| NSCLC_38242124__IMC__86_A8,14 | Lung | Primary cancer | 2,257 | Tumor/Malignant | 38.7% | 0.89 | 0.35 |
| NSCLC_38242124__IMC__86_A8,2 | Lung | Primary cancer | 868 | Tumor/Malignant | 47.0% | 0.93 | 0.24 |
| NSCLC_38242124__IMC__86_A8,3 | Lung | Primary cancer | 3,118 | Tumor/Malignant | 50.5% | 0.98 | 0.09 |
| NSCLC_38242124__IMC__86_A8,4 | Lung | Primary cancer | 3,640 | Tumor/Malignant | 29.1% | 0.93 | 0.24 |
Spatial Domain (Tier 2)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__86_A6,9 | Lung | Primary cancer | 1,491 | Tumor/Malignant | 42.5% | 0.94 | 0.21 |
| NSCLC_38242124__IMC__86_A7,1 | Lung | Primary cancer | 2,317 | Tumor/Malignant | 58.9% | 0.97 | 0.08 |
| NSCLC_38242124__IMC__86_A7,10 | Lung | Primary cancer | 2,375 | Tumor/Malignant | 31.2% | 0.96 | 0.19 |
| NSCLC_38242124__IMC__86_A7,11 | Lung | Primary cancer | 2,116 | Stromal | 43.2% | 0.88 | 0.34 |
| NSCLC_38242124__IMC__86_A7,12 | Lung | Primary cancer | 540 | Other | 64.1% | 0.98 | 0.07 |
| NSCLC_38242124__IMC__86_A7,13 | Lung | Primary cancer | 4,267 | Tumor/Malignant | 26.4% | 0.93 | 0.22 |
| NSCLC_38242124__IMC__86_A7,2 | Lung | Primary cancer | 2,945 | Tumor/Malignant | 42.9% | 0.90 | 0.32 |
| NSCLC_38242124__IMC__86_A7,4 | Lung | Primary cancer | 4,008 | Tumor/Malignant | 24.2% | 0.59 | 0.91 |
| NSCLC_38242124__IMC__86_A7,5 | Lung | Primary cancer | 3,313 | Tumor/Malignant | 82.9% | 0.99 | 0.05 |
| NSCLC_38242124__IMC__86_A7,7 | Lung | Primary cancer | 1,967 | Tumor/Malignant | 48.9% | 0.73 | 0.59 |
| NSCLC_38242124__IMC__86_A7,8 | Lung | Primary cancer | 2,968 | Stromal | 49.4% | 0.96 | 0.14 |
| NSCLC_38242124__IMC__86_A7,9 | Lung | Primary cancer | 2,881 | Tumor/Malignant | 25.0% | 0.47 | 1.03 |
| NSCLC_38242124__IMC__86_A8,1 | Lung | Primary cancer | 2,834 | Tumor/Malignant | 28.3% | 0.79 | 0.61 |
| NSCLC_38242124__IMC__86_A8,10 | Lung | Primary cancer | 3,285 | Stromal | 29.9% | 0.37 | 1.10 |
| NSCLC_38242124__IMC__86_A8,11 | Lung | Primary cancer | 2,883 | Stromal | 27.5% | 0.88 | 0.38 |
| NSCLC_38242124__IMC__86_A8,12 | Lung | Primary cancer | 3,110 | Tumor/Malignant | 54.6% | 0.99 | 0.05 |
| NSCLC_38242124__IMC__86_A8,14 | Lung | Primary cancer | 2,257 | Tumor/Malignant | 30.4% | 0.94 | 0.22 |
| NSCLC_38242124__IMC__86_A8,2 | Lung | Primary cancer | 868 | Tumor/Malignant | 40.0% | 0.73 | 0.56 |
| NSCLC_38242124__IMC__86_A8,3 | Lung | Primary cancer | 3,118 | Tumor/Malignant | 59.0% | 0.99 | 0.05 |
| NSCLC_38242124__IMC__86_A8,4 | Lung | Primary cancer | 3,640 | Tumor/Malignant | 30.2% | 0.93 | 0.26 |
Spatial Domain (Tier 3)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__86_A6,9 | Lung | Primary cancer | 1,491 | Tumor/Malignant cell | 43.7% | 0.93 | 0.22 |
| NSCLC_38242124__IMC__86_A7,1 | Lung | Primary cancer | 2,317 | Tumor/Malignant cell | 59.0% | 0.97 | 0.08 |
| NSCLC_38242124__IMC__86_A7,10 | Lung | Primary cancer | 2,375 | Tumor/Malignant cell | 34.2% | 0.94 | 0.25 |
| NSCLC_38242124__IMC__86_A7,11 | Lung | Primary cancer | 2,116 | Fibroblast | 42.5% | 0.87 | 0.35 |
| NSCLC_38242124__IMC__86_A7,12 | Lung | Primary cancer | 540 | Other | 68.5% | 0.97 | 0.09 |
| NSCLC_38242124__IMC__86_A7,13 | Lung | Primary cancer | 4,267 | Tumor/Malignant cell | 28.1% | 0.91 | 0.27 |
| NSCLC_38242124__IMC__86_A7,2 | Lung | Primary cancer | 2,945 | Tumor/Malignant cell | 45.3% | 0.90 | 0.34 |
| NSCLC_38242124__IMC__86_A7,4 | Lung | Primary cancer | 4,008 | Tumor/Malignant cell | 31.1% | 0.84 | 0.55 |
| NSCLC_38242124__IMC__86_A7,5 | Lung | Primary cancer | 3,313 | Tumor/Malignant cell | 86.9% | 0.98 | 0.07 |
| NSCLC_38242124__IMC__86_A7,7 | Lung | Primary cancer | 1,967 | Tumor/Malignant cell | 53.4% | 0.90 | 0.29 |
| NSCLC_38242124__IMC__86_A7,8 | Lung | Primary cancer | 2,968 | Fibroblast | 42.6% | 0.96 | 0.15 |
| NSCLC_38242124__IMC__86_A7,9 | Lung | Primary cancer | 2,881 | Tumor/Malignant cell | 25.3% | 0.90 | 0.30 |
| NSCLC_38242124__IMC__86_A8,1 | Lung | Primary cancer | 2,834 | Tumor/Malignant cell | 36.1% | 0.74 | 0.69 |
| NSCLC_38242124__IMC__86_A8,10 | Lung | Primary cancer | 3,285 | Fibroblast | 24.4% | 0.62 | 0.89 |
| NSCLC_38242124__IMC__86_A8,11 | Lung | Primary cancer | 2,883 | Fibroblast | 39.0% | 0.77 | 0.57 |
| NSCLC_38242124__IMC__86_A8,12 | Lung | Primary cancer | 3,110 | Tumor/Malignant cell | 61.5% | 0.98 | 0.07 |
| NSCLC_38242124__IMC__86_A8,14 | Lung | Primary cancer | 2,257 | Tumor/Malignant cell | 40.0% | 0.88 | 0.37 |
| NSCLC_38242124__IMC__86_A8,2 | Lung | Primary cancer | 868 | Tumor/Malignant cell | 43.7% | 0.94 | 0.22 |
| NSCLC_38242124__IMC__86_A8,3 | Lung | Primary cancer | 3,118 | Tumor/Malignant cell | 64.4% | 0.98 | 0.09 |
| NSCLC_38242124__IMC__86_A8,4 | Lung | Primary cancer | 3,640 | Tumor/Malignant cell | 36.7% | 0.89 | 0.36 |